SubHero Banner

Purified Cortrophin Gel (repository corticotropin) – New drug approval

November 1, 2021 - ANI Pharmaceuticals announced the FDA approval of Purified Cortrophin Gel (repository corticotropin), for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis (MS) and rheumatoid arthritis, in addition to excess urinary protein due to nephrotic syndrome.

Download PDF